]> C44.1 Eyelid Note: Laterality must be coded for this site. &commontumorsize_drone; CS Extension Note 1: In the case of multiple simultaneous tumors, code the tumor with greatest extension. Note 2: Skin ulceration does not alter the AJCC T category. Note 3: Presence of tumor at eyelid margin takes priority over depth of invasion in dermis/tarsal plate; i.e., code 250 takes priority over codes 100-200. Note 4: Metastatic skin lesions are coded in CS Mets at DX. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 000 Tis Tis IS IS 100 ^ * L L 150 ^ * L L 155 Stated as T1 with no other information on extension ^ * L L 200 Tumor invades tarsal plate, not at eyelid margin ^ * L L 250 Tumor at eyelid margin ^ * L L 270 Stated as T2a with no other information on extension ^ * L L 300 Tumor involves full eyelid thickness ^ * L L 320 Stated as T2b with no other information on extension ^ * L L 340 Stated as T2 [NOS] with no other information on extension ^ * L L 400 Localized, NOS ^ * L L 500 ERROR ERROR ERROR ERROR 600 ERROR T4 D RE 610 T3a T4 D RE 620 T3a T4 D RE 650 Stated as T3a with no other information on extension T3a T3 D RE 670 T3b T4 D RE 690 Stated as T3 [NOS] with no other information on extension T3NOS T4 D RE 700 ERROR ERROR ERROR ERROR 715 T4 T4 D RE 720 T4 T4 D D 740 Central nervous system T4 T4 D D 750 ERROR ERROR ERROR ERROR 800 Further contiguous extension T4 T4 D D 810 Stated as T4 with no other information on extension T4 T4 D D 950 No evidence of primary tumor T0 T0 U U 999 TX TX U U ^ For CS Extension codes 100-400 ONLY, the T category for AJCC 7 staging is assigned based on the value of CS Tumor Size, CS Extension, and Perineural Invasion recorded in CS Site-Specific Factor 6, as shown in the Extension Size, Perineural Invasion Negative or Unknown AJCC 7 Table, the Extension Size, Perineural Invasion Positive AJCC 7 Table, and the Extension Size, Perineural Invasion 888, 988 Table for this schema. * For cases coded in CSv1 (CS Version Input Original equals 01XXXX) and Year of Diagnosis is less than 2010 and CS-Site Specific Factor 6, Perineural Invasion = 988 or blank, the T category for AJCC 6 staging is assigned based on the value of CS Tumor Size and CS Extension as shown in the Extension Size AJCC 6 Table CSv1 for this schema. For cases coded in CSv2 and cases coded in CSv1 with Year of Diagnosis less than 2010 and Perineural Invasion not coded to 988 or blank, using CS Extension codes 100-400 ONLY, the T category for AJCC 6 staging is assigned based on the value of CS Tumor Size, CS Extension, and Perineural Invasion recorded in CS Site-Specific Factor 6, as shown in the Extension Size, Perineural Invasion Negative or Unknown AJCC 6 Table CSv2, the Extension Size, Perineural Invasion Positive AJCC 6 Table CSv2, and the Extension Size, Perineural Invasion 888, 988 Table CSv2 for this schema. &generalcstsexteval; CS Lymph Nodes Note: Code only regional nodes and nodes, NOS in this field. Distant nodes are coded in CS Mets at DX. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 000 No regional lymph node involvement N0 N0 NONE NONE 100 N1 N1 RN RN 120 N1 N1 D D 125 Stated as N1 with no other information on regional lymph nodes N1 N1 RN RN 800 Lymph nodes, NOS N1 N1 RN RN 999 NX NX U U &commonregnodesevalskineyelidorbit; &generalreglnpos; &generalreglnexam; CS Mets at DX Note: Codes with metastatic skin lesions include cases coded in CS Extension in CS Version 1, converted to CS Mets at DX in CS Version 2. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 00 No distant metastasis M0 M0 NONE NONE 10 M1 M1 D D 20 Metastatic skin lesions M1 M1 D D 30 M1 M1 D D 40 M1 M1 D D 50 M1 M1 D D 55 M1 M1 D D 58 M1 M1 D D 60 M1 M1 D D 99 M0 MX U U &generalmetseval; CS Site-Specific Factor 1 Measured Thickness (Depth) for Squamous Cell Carcinoma Note 1: Code measured thickness (depth) of tumor, not size, diameter, or any other measurement. Record actual measurement to nearest hundredth of millimeter (mm) from pathology report. Note 2: Record only for squamous cell carcinoma of skin of eyelid. For other histologies use code 987, not applicable. Code Description 000 No mass/tumor found 001-979 980 9.80 mm or larger 987 Not applicable, not squamous cell carcinoma of skin of eyelid 988 990 998 No histologic examination of primary site 999 CS Site-Specific Factor 2 Clark Level Note 1: Code the Clark level as documented in the pathology report. Note 2: Record only for squamous cell carcinoma of skin of eyelid. For other histologies, use code 987, not applicable. Code Description 010 020 030 040 050 888 987 Not applicable, not squamous cell carcinoma of skin of eyelid 988 998 No histologic examination of primary site 999 CS Site-Specific Factor 3 Clinical Status of Lymph Nodes Code Description 000 Negative clinical or radiographic examination of lymph nodes 010 Positive clinical or radiographic examination of lymph nodes 888 988 997 Nodes examined clinically and/or radiographically, unknown results 998 No clinical or radiographic examination of lymph nodes 999 CS Site-Specific Factor 4 Size of Lymph Nodes Note 1: Code the largest diameter, whether measured clinically or pathologically, of any involved regional lymph node(s). Do not code the size of any nodes coded in CS Mets at DX. Note 2: Record only for squamous cell carcinoma of skin of eyelid. For other histologies, code 987, not applicable. Code Description 000 No involved regional lymph nodes 001-979 980 980 mm or larger 987 Not applicable, not squamous cell carcinoma of skin of eyelid 988 990 Microscopic focus or foci only and no size of focus given 991 Described as "less than 1 centimeter (cm)" 992 Described as "less than 2cm" or "greater than 1cm" or between 1cm and 2cm" 993 Described as "less than 3cm" or "greater than 2cm" or "between 2cm and 3cm" 994 Described as "less than 4cm" or "greater than 3cm" or "between 3cm and 4cm" 995 Described as "less than 5cm" or "greater than 4cm" or "between 4cm and 5cm" 996 Described as "less than 6cm" or "greater than 5 cm" or "between 5cm and 6cm" 997 Described as "more than 6cm" 999 CS Site-Specific Factor 5 Sentinel Lymph Node Biopsy Code Description 000 Negative sentinel lymph node biopsy 010 Positive sentinel lymph node biopsy 888 988 997 Sentinel node biopsy performed, unknown results 998 No sentinel node biopsy performed 999 CS Site-Specific Factor 6 Perineural Invasion Note: Code the presence or absence of perineural invasion as documented in the pathology report. Use code 000 if histologic examination of primary site was performed, the pathology report is available for review, and perineural invasion is not mentioned. Code Description 000 Perineural invasion not present/not identified 010 Perineural invasion present/identified 888 988 997 Histologic examination of primary site performed, unknown results 998 No histologic examination of primary site 999 CS Site-Specific Factor 7 Tumor Necrosis Note: Code the presence or absence of tumor necrosis as documented in the pathology report. Assign code 000 if histologic examination of primary site was performed, the pathology report is available for review, and tumor necrosis is not mentioned. Code Description 000 Tumor necrosis not present/not identified 010 Tumor necrosis present/identified 988 997 Histologic examination of primary site performed, unknown results 998 No histologic examination of primary site 999 CS Site-Specific Factor 8 Pagetoid Spread Note: Code the presence or absence of Pagetoid spread as documented in the pathology report. Assign code 000 if histologic examination was performed, the pathology report is available for review, and Pagetoid spread is not mentioned. Code Description 000 Pagetoid spread not present/not identified 010 Pagetoid spread present/identified 988 997 Histologic examination of primary site performed, results not available 998 No histologic examination of primary site 999 CS Site-Specific Factor 9 Mohs Layers Note 1: Code the number of Mohs micrographic surgical layers required to clear the tumor, as stated on the operative report. Note 2: Use codes 991, 992, and 997 only if the specific number of Mohs layers is not documented. Code Description 001-010 011 11 or more Mohs micrographic surgical layers required to clear tumor 988 991 Less than 3 Mohs micrographic surgical layers required to clear tumor 992 Greater than 3 Mohs micrographic surgical layers required to clear tumor 997 Mohs surgery performed, unknown number of micrographic surgical layers required to clear tumor 998 Mohs surgery not performed 999 CS Site-Specific Factor 10 Prior Radiation Note: Code history of prior radiation to the tumor field as documented by the physician in the medical record. Code Description 000 No history of prior radiation to tumor field 010 History of prior radiation to tumor field 988 999 CS Site-Specific Factor 11 Human Immunodeficiency Virus (HIV) Status Note 1: Human Immunodeficiency Virus (HIV) includes types I and II. Older terminology includes Human T-Lymphotropic Virus (HTLV-3) and Lymphadenopathy Associated Virus (LAV). Note 2: Code HIV status as identified in the medical record. Code Description 000 Negative Human Immunodeficiency Virus (HIV) status 010 Positive HIV status 988 999 CS Site-Specific Factor 12 Solid Organ Transplant Note: Code history of any solid organ transplant as identified in the medical record. Transplanted organs may include heart, lungs, kidney, pancreas, liver. Code Description 000 No history of solid organ transplant 010 History of solid organ transplant 988 999 CS Site-Specific Factor 13 Leukemia Note: Code history of leukemia as documented by the physician in the medical record. Do not code from results of complete blood count (CBC) or whit blood count (WBC.) Code Description 000 No history of leukemia 010 History of leukemia 988 999 CS Site-Specific Factor 14 Multiple Carcinomas Note: Code a history of two or more carcinomas as documented by the physician or as found in the medical record or registry database. Include in the identification of "carcinoma" any tumor with a histology code between 8010 and 8589, excluding all carcinomas of skin coded to site C440-C449. Code Description 000 No history of two or more carcinomas excluding skin carcinoma 010 History of two or more carcinomas excluding skin carcinoma 988 999 CS Site-Specific Factor 15 Muir-Torre Syndrome Note 1: Muir-Torre syndrome is a rare autosomal dominant condition in which multiple primary malignancies occur together with a sebaceous gland tumor. It is defined by the combination of at least one sebaceous adenoma, epithelioma, or carcinoma, and at least one visceral carcinoma occurring in the same individual in the absence of other precipitating factors such as radiotherapy or Autoimmune Immunodeficiency Syndrome (AIDS). Note 2: Code history of Muir-Torre Ssyndrome as documented by the physician in the medical record. Code Description 000 No history of Muir-Torre Syndrome 010 History of Muir-Torre Syndrome 988 999 CS Site-Specific Factor 16 Xeroderma Pigmentosa Note 1: Xeroderma pigmentosa is a very rare hereditary condition characterized by extreme sensitivity to ultraviolet radiation in sunlight, with a very high risk for skin cancer and eye problems especially of the eyelids. Note 2: Code xeroderma pigmentosa as documented by the physician in the medical record. Code Description 000 No history of xeroderma pigmentosa 010 History of xeroderma pigmentosa 988 999 ¬appnewssf17; ¬appnewssf18; ¬appnewssf19; ¬appnewssf20; ¬appnewssf21; ¬appnewssf22; ¬appnewssf23; ¬appnewssf24; ¬appnewssf25; &commonhistinclusioncarcinoma; Histology Exclusion Table AJCC 6th ed. Note: Histology codes listed in this Histology Exclusion Table for this site are codes that are not TNM staged according to the AJCC 6th Edition Cancer Staging Manual. When a case is coded in Collaborative Staging and the histology is on the exclusion list, TNM will not be calculated but SEER algorithm Summary Stage 1977 and 2000 can be assigned. For these cases, displayed results will be "T NA N NA M NA and Stage Group NA". Code Description 8240/1 Carcinoid tumor of uncertain malignant potential 8240/3 Carcinoid tumor, NOS (except of appendix M-8240/1) 8241/3 Enterochromaffin cell carcinoid 8242/1 Enterochromaffin-like cell carcinoid, NOS 8242/3 Enterochromaffin-like cell tumor, malignant 8243/3 Goblet cell carcinoid 8248/1 Apudoma 8680/0 Paraganglioma, benign 8680/1 Paraganglioma, NOS 8680/3 Paraganglioma, malignant 8681/1 Sympathetic paraganglioma 8682/1 Parasympathetic paraganglioma 8683/0 Gangliocytic paraganglioma (C17.0) 8690/1 Glomus jugulare tumor, NOS (C75.5) 8691/1 Aortic body tumor (C75.5) 8692/1 Carotid body tumor (C75.4) 8693/1 Extra-adrenal paraganglioma, NOS 8693/3 Extra-adrenal paraganglioma, malignant 8700/0 Pheochromocytoma, NOS (C74.1) 8700/3 Pheochromocytoma, malignant (C74.1) 8720/0 Pigmented nevus, NOS (C44._) 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS (except juvenile melanoma M-8770/0) 8721/3 Nodular melanoma (C44._) 8722/0 Balloon cell nevus (C44._) 8722/3 Balloon cell melanoma (C44._) 8723/0 Halo nevus (C44._) 8723/3 Malignant melanoma, regressing (C44._) 8725/0 Neuronevus (C44._) 8726/0 Magnocellular nevus (C69.4) 8727/0 Dysplastic nevus (C44._) 8728/0 Diffuse melanocytosis (C70.9) 8728/1 Meningeal melanocytoma (C70.9) 8728/3 Meningeal melanomatosis (C70.9) 8730/0 Nonpigmented nevus (C44._) 8730/3 Amelanotic melanoma (C44._) 8740/0 Junctional nevus, NOS (C44._) 8740/3 Malignant melanoma in junctional nevus (C44._) 8741/2 Precancerous melanosis, NOS (C44._) 8741/3 Malignant melanoma in precancerous melanosis (C44._) 8742/2 Lentigo maligna (C44._) 8742/3 Lentigo maligna melanoma (C44._) 8743/3 Superficial spreading melanoma (C44._) 8744/3 Acral lentiginous melanoma, malignant (C44._) 8745/3 Desmoplastic melanoma, malignant (C44._) 8746/3 Mucosal lentiginous melanoma 8750/0 Intradermal nevus (C44._) 8760/0 Compound nevus (C44._) 8761/0 Small congenital nevus (C44._) 8761/1 Giant pigmented nevus, NOS (C44._) 8761/3 Malignant melanoma in giant pigmented nevus (C44._) 8762/1 Proliferative dermal lesion in congenital nevus (C44._) 8770/0 Epithelioid and spindle cell nevus (C44._) 8770/3 Mixed epithelioid and spindle cell melanoma 8771/0 Epithelioid cell nevus (C44._) 8771/3 Epithelioid cell melanoma 8772/0 Spindle cell nevus, NOS (C44._) 8772/3 Spindle cell melanoma, NOS 8773/3 Spindle cell melanoma, type A (C69._) 8774/3 Spindle cell melanoma, type B (C69._) 8780/0 Blue nevus, NOS (C44._) 8780/3 Blue nevus, malignant (C44._) 8790/0 Cellular blue nevus (C44._) 8930/0 Endometrial stromal nodule (C54.1) 8930/3 Endometrial stromal sarcoma, NOS (C54.1) 8931/3 Endometrial stromal sarcoma, low grade (C54.1) 8932/0 Adenomyoma 8933/3 Adenosarcoma 8934/3 Carcinofibroma 8935/0 Stromal tumor, benign 8935/1 Stromal tumor, NOS 8935/3 Stromal sarcoma, NOS 8936/0 Gastrointestinal stromal tumor, benign 8936/1 Gastrointestinal stromal tumor, NOS 8936/3 Gastrointestinal stromal sarcoma 8950/3 Mullerian mixed tumor (C54._) 8951/3 Mesodermal mixed tumor 8959/0 Benign cystic nephroma (C64.9) 8959/1 Cystic partially differentiated nephroblastoma (C64.9) 8959/3 Malignant cystic nephroma (C64.9) 8960/1 Mesoblastic nephroma 8960/3 Nephroblastoma, NOS (C64.9) 8963/3 Malignant rhabdoid tumor 8964/3 Clear cell sarcoma of kidney (C64.9) 8965/0 Nephrogenic adenofibroma (C64.9) 8966/0 Renomedullary interstitial cell tumor (C64.9) 8967/0 Ossifying renal tumor (C64.9) 8970/3 Hepatoblastoma (C22.0) 8971/3 Pancreatoblastoma (C25._) 8972/3 Pulmonary blastoma (C34._) 8973/3 Pleuropulmonary blastoma 8974/1 Sialoblastoma 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal 8982/0 Myoepithelioma 8982/3 Malignant myoepithelioma 8983/0 Adenomyoepithelioma (C50._) 9000/0 Brenner tumor, NOS (C56.9) 9000/1 Brenner tumor, borderline malignancy (C56.9) 9000/3 Brenner tumor, malignant (C56.9) 9010/0 Fibroadenoma, NOS (C50._) 9011/0 Intracanalicular fibroadenoma (C50._) 9012/0 Pericanalicular fibroadenoma (C50._) 9013/0 Adenofibroma, NOS 9014/0 Serous adenofibroma, NOS 9014/1 Serous adenofibroma of borderline malignancy 9014/3 Serous adenocarcinofibroma 9015/0 Mucinous adenofibroma, NOS 9015/1 Mucinous adenofibroma of borderline malignancy 9015/3 Mucinous adenocarcinofibroma 9016/0 Giant fibroadenoma (C50._) 9020/0 Phyllodes tumor, benign (C50._) 9020/1 Phyllodes tumor, borderline (C50._) 9020/3 Phyllodes tumor, malignant (C50._) 9030/0 Juvenile fibroadenoma (C50._) 9050/0 Mesothelioma, benign 9050/3 Mesothelioma, malignant 9051/0 Fibrous mesothelioma, benign 9051/3 Fibrous mesothelioma, malignant 9052/0 Epithelioid mesothelioma, benign 9052/3 Epithelioid mesothelioma, malignant 9053/3 Mesothelioma, biphasic, malignant 9054/0 Adenomatoid tumor, NOS 9055/0 Multicystic mesothelioma, benign 9055/1 Cystic mesothelioma, NOS (C48._) 9060/3 Dysgerminoma 9061/3 Seminoma, NOS (C62._) 9062/3 Seminoma, anaplastic (C62._) 9063/3 Spermatocytic seminoma (C62._) 9064/2 Intratubular malignant germ cells (C62._) 9064/3 Germinoma 9065/3 Germ cell tumor, nonseminomatous (C62._) 9070/3 Embryonal carcinoma, NOS 9071/3 Yolk sac tumor 9072/3 Polyembryoma 9073/1 Gonadoblastoma 9080/0 Teratoma, benign 9080/1 Teratoma, NOS 9080/3 Teratoma, malignant, NOS 9081/3 Teratocarcinoma 9082/3 Malignant teratoma, undifferentiated 9083/3 Malignant teratoma, intermediate 9084/0 Dermoid cyst, NOS 9084/3 Teratoma with malignant transformation 9085/3 Mixed germ cell tumor 9090/0 Struma ovarii, NOS (C56.9) 9090/3 Struma ovarii, malignant (C56.9) 9091/1 Strumal carcinoid (C56.9) 9100/0 Hydatidiform mole, NOS (C58.9) 9100/1 Invasive hydatidiform mole (C58.9) 9100/3 Choriocarcinoma, NOS 9101/3 Choriocarcinoma combined with other germ cell elements 9102/3 Malignant teratoma, trophoblastic 9103/0 Partial hydatidiform mole (C58.9) 9104/1 Placental site trophoblastic tumor (C58.9) 9105/3 Trophoblastic tumor, epithelioid 9110/0 Mesonephroma, benign 9110/1 Mesonephric tumor, NOS 9110/3 Mesonephroma, malignant 9140/3 Kaposi sarcoma 9141/0 Angiokeratoma 9142/0 Verrucous keratotic hemangioma 9260/3 Ewing sarcoma 9261/3 Adamantinoma of long bones (C40._) 9262/0 Ossifying fibroma 9270/0 Odontogenic tumor, benign 9270/1 Odontogenic tumor, NOS 9270/3 Odontogenic tumor, malignant 9271/0 Ameloblastic fibrodentinoma 9272/0 Cementoma, NOS 9273/0 Cementoblastoma, benign 9274/0 Cementifying fibroma 9275/0 Gigantiform cementoma 9280/0 Odontoma, NOS 9281/0 Compound odontoma 9282/0 Complex odontoma 9290/0 Ameloblastic fibro-odontoma 9290/3 Ameloblastic odontosarcoma 9300/0 Adenomatoid odontogenic tumor 9301/0 Calcifying odontogenic cyst 9302/0 Odontogenic ghost cell tumor 9310/0 Ameloblastoma, NOS 9310/3 Ameloblastoma, malignant 9311/0 Odontoameloblastoma 9312/0 Squamous odontogenic tumor 9320/0 Odontogenic myxoma 9321/0 Central odontogenic fibroma 9322/0 Peripheral odontogenic fibroma 9330/0 Ameloblastic fibroma 9330/3 Ameloblastic fibrosarcoma 9340/0 Calcifying epithelial odontogenic tumor 9341/1 Clear cell odontogenic tumor 9342/3 Odontogenic carcinosarcoma 9350/1 Craniopharyngioma (C75.2) 9351/1 Craniopharyngioma, adamantinomatous (C75.2) 9352/1 Craniopharyngioma, papillary (C75.2) 9360/1 Pinealoma (C75.3) 9361/1 Pineocytoma (C75.3) 9362/3 Pineoblastoma (C75.3) 9363/0 Melanotic neuroectodermal tumor 9364/3 Peripheral neuroectodermal tumor 9365/3 Askin tumor 9380/3 Glioma, malignant (C71._) 9381/3 Gliomatosis cerebri (C71._) 9382/3 Mixed glioma (C71._) 9383/1 Subependymoma (C71._) 9384/1 Subependymal giant cell astrocytoma (C71._) 9390/0 Choroid plexus papilloma, NOS (C71.5) 9390/1 Atypical choroid plexus papilloma (C71.5) 9390/3 Choroid plexus carcinoma (C71.5) 9391/3 Ependymoma, NOS (C71._) 9392/3 Ependymoma, anaplastic (C71._) 9393/3 Papillary ependymoma (C71._) 9394/1 Myxopapillary ependymoma (C72.0) 9400/3 Astrocytoma, NOS (C71._) 9401/3 Astrocytoma, anaplastic (C71._) 9410/3 Protoplasmic astrocytoma (C71._) 9411/3 Gemistocytic astrocytoma (C71._) 9412/1 Desmoplastic infantile astrocytoma (C71._) 9413/0 Dysembryoplastic neuroepithelial tumor 9420/3 Fibrillary astrocytoma (C71._) 9421/1 Pilocytic astrocytoma (C71._) 9423/3 Polar spongioblastoma (C71._) 9424/3 Pleomorphic xanthoastrocytoma (C71._) 9430/3 Astroblastoma (C71._) 9440/3 Glioblastoma, NOS (C71._) 9441/3 Giant cell glioblastoma (C71._) 9442/1 Gliofibroma (C71._) 9442/3 Gliosarcoma (C71._) 9444/1 Chordoid glioma (C71._) 9450/3 Oligodendroglioma, NOS (C71._) 9451/3 Oligodendroglioma, anaplastic (C71._) 9460/3 Oligodendroblastoma (C71._) [obs] 9470/3 Medulloblastoma, NOS (C71.6) 9471/3 Desmoplastic nodular medulloblastoma (C71.6) 9472/3 Medullomyoblastoma (C71.6) 9473/3 Primitive neuroectodermal tumor, NOS 9474/3 Large cell medulloblastoma (C71.6) 9480/3 Cerebellar sarcoma, NOS (C71.6) [obs] 9490/0 Ganglioneuroma 9490/3 Ganglioneuroblastoma 9491/0 Ganglioneuromatosis 9492/0 Gangliocytoma 9493/0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6) 9500/3 Neuroblastoma, NOS 9501/0 Medulloepithelioma, benign (C69.4) 9501/3 Medulloepithelioma, NOS 9502/0 Teratoid medulloepithelioma, benign (C69.4) 9502/3 Teratoid medulloepithelioma 9503/3 Neuroepithelioma, NOS 9504/3 Spongioneuroblastoma 9505/1 Ganglioglioma, NOS 9505/3 Ganglioglioma, anaplastic 9506/1 Central neurocytoma 9507/0 Pacinian tumor 9508/3 Atypical teratoid/rhabdoid tumor (C71._) 9510/0 Retinocytoma (C69.2) 9510/3 Retinoblastoma, NOS (C69.2) 9511/3 Retinoblastoma, differentiated (C69.2) 9512/3 Retinoblastoma, undifferentiated (C69.2) 9513/3 Retinoblastoma, diffuse (C69.2) 9514/1 Retinoblastoma, spontaneously regressed (C69.2) 9520/3 Olfactory neurogenic tumor 9521/3 Olfactory neurocytoma (C30.0) 9522/3 Olfactory neuroblastoma (C30.0) 9523/3 Olfactory neuroepithelioma (C30.0) 9530/0 Meningioma, NOS 9530/1 Meningiomatosis, NOS 9530/3 Meningioma, malignant 9531/0 Meningothelial meningioma 9532/0 Fibrous meningioma 9533/0 Psammomatous meningioma 9534/0 Angiomatous meningioma 9535/0 Hemangioblastic meningioma [obs] 9537/0 Transitional meningioma 9538/1 Clear cell meningioma 9538/3 Papillary meningioma 9539/1 Atypical meningioma 9539/3 Meningeal sarcomatosis 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin, NOS 9596/3 Composite Hodgkin and non-Hodgkin lymphoma 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocyte depletion, NOS 9654/3 Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyte depletion, reticular 9659/3 Hodgkin lymphoma, nodular lymphocyte predominance 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nodular sclerosis, cellular phase 9665/3 Hodgkin lymphoma, nodular sclerosis, grade 1 9667/3 Hodgkin lymphoma, nodular sclerosis, grade 2 9670/3 Malignant lymphoma, small B lymphocytic, NOS (see also M-9823/3) 9671/3 Malignant lymphoma, lymphoplasmacytic (see also M-9761/3) 9673/3 Mantle cell lymphoma 9675/3 Malignant lymphoma, mixed small and large cell, diffuse [obs] (see also M-9690/3) 9678/3 Primary effusion lymphoma 9679/3 Mediastinal large B-cell lymphoma (C38.3) 9680/3 Malignant lymphoma, large B-cell, diffuse, NOS 9684/3 Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS (see also M-9826/3) 9689/3 Splenic marginal zone B-cell lymphoma (C42.2) 9690/3 Follicular lymphoma, NOS (see also M-9675/3) 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS 9700/3 Mycosis fungoides (C44._) 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma 9708/3 Subcutaneous panniculitis-like T-cell lymphoma 9709/3 Cutaneous T-cell lymphoma, NOS (C44._) 9714/3 Anaplastic large cell lymphoma, T cell and Null cell type 9716/3 Hepatosplenic ?? (gamma-delta) cell lymphoma 9717/3 Intestinal T-cell lymphoma 9718/3 Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._) 9719/3 NK/T-cell lymphoma, nasal and nasal-type 9727/3 Precursor cell lymphoblastic lymphoma, NOS (see also M-9835/3) 9728/3 Precursor B-cell lymphoblastic lymphoma (see also M-9836/3) 9729/3 Precursor T-cell lymphoblastic lymphoma (see also M-9837/3) 9731/3 Plasmacytoma, NOS 9732/3 Multiple myeloma (C42.1) 9733/3 Plasma cell leukemia (C42.1) 9734/3 Plasmacytoma, extramedullary (not occurring in bone) 9740/1 Mastocytoma, NOS 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9742/3 Mast cell leukemia (C42.1) 9750/3 Malignant histiocytosis 9751/1 Langerhans cell histiocytosis, NOS 9752/1 Langerhans cell histiocytosis, unifocal 9753/1 Langerhans cell histiocytosis, multifocal 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9760/3 Immunoproliferative disease, NOS 9761/3 Waldenstrom macroglobulinemia (C42.0) (see also M-9671/3) 9762/3 Heavy chain disease, NOS 9764/3 Immunoproliferative small intestinal disease (C17._) 9765/1 Monoclonal gammopathy of undetermined significance 9766/1 Angiocentric immunoproliferative lesion 9767/1 Angioimmunoblastic lymphadenopathy 9768/1 T-gamma lymphoproliferative disease 9769/1 Immunoglobulin deposition disease 9800/3 Leukemia, NOS 9801/3 Acute leukemia, NOS 9805/3 Acute biphenotypic leukemia 9820/3 Lymphoid leukemia, NOS 9823/3 B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3) 9826/3 Burkitt cell leukemia (see also M-9687/3) 9827/3 Adult T-cell leukemia/lymphoma (HTLV-1 positive) Includes all variants 9831/1 T-cell large granular lymphocytic leukemia 9832/3 Prolymphocytic leukemia, NOS 9833/3 Prolymphocytic leukemia, B-cell type 9834/3 Prolymphocytic leukemia, T-cell type 9835/3 Precursor cell lymphoblastic leukemia, NOS (see also M-9727/3) 9836/3 Precursor B-cell lymphoblastic leukemia (see also M-9728/3) 9837/3 Precursor T-cell lymphoblastic leukemia (see also M-9729/3) 9840/3 Acute myeloid leukemia, M6 type 9860/3 Myeloid leukemia, NOS 9861/3 Acute myeloid leukemia, NOS (FAB or WHO type not specified) (see also M-9930/3) 9863/3 Chronic myeloid leukemia, NOS 9866/3 Acute promyelocytic leukemia, t(15;17)(q22;q11-12) 9867/3 Acute myelomonocytic leukemia 9870/3 Acute basophilic leukemia 9871/3 Acute myeloid leukemia with abnormal marrow eosinophils Includes all variants 9872/3 Acute myeloid leukemia, minimal differentiation 9873/3 Acute myeloid leukemia without maturation 9874/3 Acute myeloid leukemia with maturation 9875/3 Chronic myelogenous leukemia, BCR/ABL positive 9876/3 Atypical chronic myeloid leukemia, BCR/ABL negative 9891/3 Acute monocytic leukemia 9895/3 Acute myeloid leukemia with multilineage dysplasia 9896/3 Acute myeloid leukemia, t(8;21)(q22;q22) 9897/3 Acute myeloid leukemia, 11q23 abnormalities 9910/3 Acute megakaryoblastic leukemia 9920/3 Therapy-related acute myeloid leukemia, NOS 9930/3 Myeloid sarcoma (see also M-9861/3) 9931/3 Acute panmyelosis with myelofibrosis (C42.1) 9940/3 Hairy cell leukemia (C42.1) 9945/3 Chronic myelomonocytic leukemia, NOS 9946/3 Juvenile myelomonocytic leukemia 9948/3 Aggressive NK-cell leukemia 9950/3 Polycythemia vera 9960/3 Chronic myeloproliferative disease, NOS 9961/3 Myelosclerosis with myeloid metaplasia 9962/3 Essential thrombocythemia 9963/3 Chronic neutrophilic leukemia 9964/3 Hypereosinophilic syndrome 9970/1 Lymphoproliferative disorder, NOS 9975/1 Myeloproliferative disease, NOS 9980/3 Refractory anemia 9982/3 Refractory anemia with sideroblasts 9983/3 Refractory anemia with excess blasts 9984/3 Refractory anemia with excess blasts in transformation [obs] 9985/3 Refractory cytopenia with multilineage dysplasia 9986/3 Myelodysplastic syndrome with 5q deletion (5q-) syndrome 9987/3 Therapy-related myelodysplastic syndrome, NOS 9989/3 Myelodysplastic syndrome, NOS AJCC TNM 7 Stage T N M Stage T0 N0 M0 ERROR T0 N1 M0 IIIB T0 NX M0 UNK Tis N0 M0 0 Tis N1 M0 ERROR Tis NX M0 0 T1 N0 M0 IA T1 N1 M0 IIIB T1 NX M0 UNK T2a N0 M0 IB T2a N1 M0 IIIB T2a NX M0 UNK T2b N0 M0 IC T2b N1 M0 IIIB T2b NX M0 UNK T2NOS N0 M0 INOS T2NOS N1 M0 IIIB T2NOS NX M0 UNK T3a N0 M0 II T3a N1 M0 IIIB T3a NX M0 UNK T3b N0 M0 IIIA T3b N1 M0 IIIB T3b NX M0 IIINOS T3NOS N0 M0 UNK T3NOS N1 M0 IIIB T3NOS NX M0 UNK T4 N0 M0 IIIC T4 N1 M0 IIIC T4 NX M0 IIIC TX N0 M0 UNK TX N1 M0 IIINOS TX NX M0 UNK T0 N0 M1 IV T0 N1 M1 IV T0 NX M1 IV Tis N0 M1 ERROR Tis N1 M1 ERROR Tis NX M1 ERROR T1 N0 M1 IV T1 N1 M1 IV T1 NX M1 IV T2a N0 M1 IV T2a N1 M1 IV T2a NX M1 IV T2b N0 M1 IV T2b N1 M1 IV T2b NX M1 IV T2NOS N0 M1 IV T2NOS N1 M1 IV T2NOS NX M1 IV T3a N0 M1 IV T3a N1 M1 IV T3a NX M1 IV T3b N0 M1 IV T3b N1 M1 IV T3b NX M1 IV T3NOS N0 M1 IV T3NOS N1 M1 IV T3NOS NX M1 IV T4 N0 M1 IV T4 N1 M1 IV T4 NX M1 IV TX N0 M1 IV TX N1 M1 IV TX NX M1 IV ¬appscsstageanytnm; &commonsummarystage; Extension Size, Perineural Invasion Negative or Unknown AJCC 7 Table Note: When CS Site-Specific Factor 6 Perineural Invasion = 000, 997, 998, or 999, for CS Extension codes 100-400 ONLY, the T category for AJCC 7 staging is assigned based on the value of CS Tumor Size and CS Extension as shown in this table. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-005 1 5 CS Tumor Size 006-010 6 10 CS Tumor Size 011-020 11 20 CS Tumor Size 021-989 21 989 CS Tumor Size 990-990 990 CS Tumor Size 991-991 991 CS Tumor Size 992-992 992 CS Tumor Size 993-995 993 995 CS Tumor Size 996-998 996 998 CS Tumor Size 999 999 100 ERROR T1 T2a T2b T3a T1 T2a T2b T3a ERROR T1 150 ERROR T1 T2a T2b T3a T1 T2a T2b T3a ERROR T1 155 ERROR T1 T2a T2b T3a T1 T2a T2b T3a ERROR T1 200 ERROR T2a T2a T2b T3a T2a T2a T2b T3a ERROR T2a 250 ERROR T2a T2a T2b T3a T2a T2a T2b T3a ERROR T1 270 ERROR T2a T2a T2b T3a T2a T2a T2b T3a ERROR T2a 300 ERROR T2b T2b T2b T3a T2b T2b T2b T3a ERROR T2b 320 ERROR T2b T2b T2b T3a T2b T2b T2b T3a ERROR T2b 340 ERROR T2NOS T2NOS T2NOS T3a T2NOS T2NOS T3a T3a ERROR T2NOS 400 ERROR T1 T2a T2b T3a T1 T2a T2b T3a ERROR TX Extension Size, Perineural Invasion Positive AJCC 7 Table Note: When CS Site-Specific Factor 6 Perineural Invasion = 010, for CS Extension codes 100- 400 ONLY, the T category for AJCC 7 staging is assigned based on the value of CS Extension as shown in this table. CS Extension CS SSF 6 010 10 100 T3a 150 T3a 155 T3a 200 T3a 250 T3a 270 T3a 300 T3a 320 T3a 340 T3a 400 T3a Extension Size, Perineural Invasion 888, 988 AJCC 7 Table Note: When CS Site-Specific Factor 6 Perineural Invasion = 888 or 988, for CS Extension codes 100 through 400 ONLY, the T category for AJCC 7 staging is assigned as shown in this table. CS Extension CS SSF 6 888 888 CS SSF 6 988 988 100 ERROR ERROR 150 ERROR ERROR 155 ERROR ERROR 200 ERROR ERROR 250 ERROR ERROR 270 ERROR ERROR 300 ERROR ERROR 320 ERROR ERROR 340 ERROR ERROR 400 ERROR ERROR Extension Size, Perineural Invasion Negative or Unknown AJCC 6 Table CSv2 Note: For CS Version 2 cases, when CS Site-Specific Factor 6 Perineural Invasion = 000, 997, 998, or 999, for CS Extension codes 100-400 ONLY, the T category for AJCC 6 staging is assigned based on the value of CS Tumor Size and CS Extension as shown in this table. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-005 1 5 CS Tumor Size 006-010 6 10 CS Tumor Size 011-989 11 989 CS Tumor Size 990 990 CS Tumor Size 991 991 CS Tumor Size 992 992 CS Tumor Size 993-995 993 995 CS Tumor Size 996-998 996 998 CS Tumor Size 999 999 100 ERROR T1 T1 T1 T1 T1 T1 T1 ERROR T1 150 ERROR T1 T1 T1 T1 T1 T1 T1 ERROR T1 155 ERROR T1 T1 T1 T1 T1 T1 T1 ERROR T1 200 ERROR T2 T2 T2 T2 T2 T2 T2 ERROR T2 250 ERROR T1 T2 T3 T1 T2 T2 T3 ERROR TX 270 ERROR TX TX TX TX TX TX TX ERROR TX 300 ERROR T3 T3 T3 T3 T3 T3 T3 ERROR T3 320 ERROR TX TX TX TX TX TX TX ERROR TX 340 ERROR TX TX TX TX TX TX TX ERROR TX 400 ERROR TX TX TX TX TX TX TX ERROR TX Extension Size, Perineural Invasion Positive AJCC 6 Table CSv2 Note: CS Version 2 cases, when CS Site-Specific Factor 6 Perineural Invasion = 010, for CS Extension codes 100-400 ONLY, the T category for AJCC 6 staging is assigned based on the value of CS Extension as shown in this table. CS Extension CS SSF 6 010 10 100 T4 150 T4 155 T4 200 T4 250 T4 270 T4 300 T4 320 T4 340 T4 400 T4 Extension Size, Perineural Invasion 888, 988 AJCC 6 Table CSv2 Note: For CS Version 2, when CS Site-Specific Factor 6 Perineural Invasion = 888 or 988, for CS Extension codes 100 through 400 ONLY, the T category for AJCC 6 staging is assigned as shown in this table. CS Extension CS SSF 6 888 888 CS SSF 6 988 988 100 ERROR ERROR 150 ERROR ERROR 155 ERROR ERROR 200 ERROR ERROR 250 ERROR ERROR 270 ERROR ERROR 300 ERROR ERROR 320 ERROR ERROR 340 ERROR ERROR 400 ERROR ERROR Extension Size AJCC 6 Table CSv1 Note: For CS Version 1 cases (CS Version Input Original equals 01XXXX) and Year of Diagnosis is less than 2010 and CS Site-Specific Factor 6 Perineural Invasion = 988 or blank, for CS Extension codes 100-400 ONLY, the T category for AJCC 6 staging is assigned based on the value of CS Tumor Size and CS Extension as shown in this table. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-005 1 5 CS Tumor Size 006-010 6 10 CS Tumor Size 011-989 11 989 CS Tumor Size 990 990 CS Tumor Size 991 991 CS Tumor Size 992 992 CS Tumor Size 993-995 993 995 CS Tumor Size 996-998 996 998 CS Tumor Size 999 999 100 ERROR T1 T1 T1 T1 T1 T1 T1 ERROR T1 150 ERROR T1 T1 T1 T1 T1 T1 T1 ERROR T1 155 ERROR T1 T1 T1 T1 T1 T1 T1 ERROR T1 200 ERROR T2 T2 T2 T2 T2 T2 T2 ERROR T2 250 ERROR T1 T2 T3 T1 T2 T2 T3 ERROR TX 270 ERROR TX TX TX TX TX TX TX ERROR TX 300 ERROR T3 T3 T3 T3 T3 T3 T3 ERROR T3 320 ERROR TX TX TX TX TX TX TX ERROR TX 340 ERROR TX TX TX TX TX TX TX ERROR TX 400 ERROR T1 T1 T1 T1 T1 T1 T1 ERROR T1